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Background
Non-sterilizing HIV-1 vaccines may provide public health
benefits if they significantly reduce plasma HIV-1 RNA,
thus potentially reducing infectiousness.  Quantification
of reduction in plasma HIV-1 RNA needed to decrease
HIV-1 transmission is useful for design of efficacy trials of
candidate HIV-1 vaccines.  We modeled the relationship
between plasma HIV-1 RNA and HIV-1 transmission
using data from a prospective study of African heterosex-
ual HIV-1 serodiscordant couples. 
Methods
3408 HIV-1-infected participants with CD4 counts ≥250
cells/mm3 enrolled in the Partners in Prevention HSV/
HIV Transmission Study and their partners were followed
for ≤24 months.  HIV-1 transmission events were assessed
for viral genetic linkage within the enrolled partnership by
determining HIV-1 env and gag sequences from partners.
The relationship between plasma HIV-1 RNA over time
and risk of genetically linked HIV-1 transmission was
evaluated with a Cox model with a natural cubic spline.
Results
84 post-enrollment linked HIV-1 transmissions were
observed. HIV-1 incidence increased rapidly and non-lin-
early with higher plasma HIV-1: from 0.53 transmissions
per 100 person-years for plasma HIV-1 RNA <10,000 cop-
ies/mL to 6.2 for HIV-1 RNA >1,000,000 copies/mL
(p<0.0001). Baseline HIV-1 RNA in men was, on average,
0.4 log10 higher than in women; no significant difference
in risk of transmission for a given HIV-1 level was
observed between men and women (p = 0.17).  Given the
distribution of plasma HIV-1 RNA in this population of
stable cohabiting couples, our modeling predicts that a
0.74 log10 reduction in average plasma HIV-1 RNA in the
population would be required for a 50% reduction in
HIV-1 transmission risk.
Conclusion
This analysis provides a detailed description of the rela-
tionship between plasma HIV-1 RNA and risk of hetero-
sexual HIV-1 transmission.  These findings suggest targets
for reduction in HIV-1 RNA for use in evaluating non-ster-
ilizing HIV-1 vaccine candidates in HIV-1 infected persons
to reduce risk of heterosexual HIV-1 transmission.
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